Sheri L. Holmen
- Molecular Biology top 5%
- Oncology top 5%
- Genetics top 2%
- Cancer Research top 5%
- Genetics top 5%
- Co-authors
- Bart O. WilliamsHoward ColmanAdam L. CohenCassandra R. ZylstraMary BouxseinMatthew W. VanBrocklinMatthew L. WarmanMinrong Ai
- Topics
- Melanoma and MAPK Pathways (26 papers)Glioma Diagnosis and Treatment (12 papers)Cancer Mechanisms and Therapy (11 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Sheri L. Holmen
60 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Molecular Biology 2.1k
- Oncology 784
- Genetics 572
- Cancer Research 450
- Genetics 407
Countries citing papers authored by Sheri L. Holmen
This map shows the geographic impact of Sheri L. Holmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheri L. Holmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheri L. Holmen more than expected).
Fields of papers citing papers by Sheri L. Holmen
This network shows the impact of papers produced by Sheri L. Holmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheri L. Holmen. The network helps show where Sheri L. Holmen may publish in the future.
Co-authorship network of co-authors of Sheri L. Holmen
This figure shows the co-authorship network connecting the top 25 collaborators of Sheri L. Holmen. A scholar is included among the top collaborators of Sheri L. Holmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheri L. Holmen. Sheri L. Holmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 21 | |
| 7 | 44 | |
| 8 | 4 | |
| 9 | 40 | |
| 10 | 72 | |
| 11 | 17 | |
| 12 | 9 | |
| 13 | 105 | |
| 14 | 25 | |
| 15 | 23 | |
| 16 | 29 | |
| 17 | 59 | |
| 18 | 7 | |
| 19 | 31 | |
| 20 | 46 |
About Sheri L. Holmen
Sheri L. Holmen is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine, having authored 63 papers that have together received 3.0k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (26 papers), Glioma Diagnosis and Treatment (12 papers) and Cancer Mechanisms and Therapy (11 papers). The work is most often cited by research in Genetics (572 citations), Molecular Biology (2.1k citations) and Cancer Research (450 citations). Sheri L. Holmen has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Bart O. Williams, Howard Colman, Adam L. Cohen, Cassandra R. Zylstra, Mary Bouxsein, Matthew W. VanBrocklin, Matthew L. Warman, Minrong Ai, James P. Robinson and Marie–Claude Faugere. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.